査読有
doi：10.1016/j.seminoncol.2025.152348
PubMed No.：40494131
2023 Impact Factor：3.0
種類：原著
誌名：Seminars in oncology
発行年月：2025年6月
巻号頁：52: 152348, 2025
論題：Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population
著者：Francesco Vitiello, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Francesco Tovoli, Takashi Kumada, Mario Scartozzi, Emiliano Tamburini, Francesco Giuseppe Foschi, Mara Persano, Federico Rossari, Silvia Foti, Silvia Camera, Francesco De Cobelli, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini, Margherita Rimini
